"The remarkable capacity of iPSCs to self-renew and differentiate into any cell type makes them a highly versatile tool, but it also means they can accumulate mutations over time, particularly when expanded over extended periods. This introduces the risk of tumourigenesis, where mutations could lead to uncontrolled cell growth and potentially result in cancer."
https://www.drugtargetreview.com/article/156139/experts-explore-the-future-of-ipsc-based-cell-therapies/
Do you still want to say that this is not up to date, and the concerns for IPSC treatments by the leading scientists in the world are rubbish?
Yes it has a future many many years in the future, when it can be proven to be safe.
"The remarkable capacity of iPSCs to self-renew and...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.0¢ | 16.5¢ | $39.66K | 238.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 277684 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 14285 | 1 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |